Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Moodys
Medtronic
Express Scripts
Boehringer Ingelheim
McKesson

Last Updated: August 15, 2022

ARESTIN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Which patents cover Arestin, and what generic alternatives are available?

Arestin is a drug marketed by Orapharma and is included in one NDA. There are two patents protecting this drug.

This drug has sixteen patent family members in thirteen countries.

The generic ingredient in ARESTIN is minocycline hydrochloride. There are fifteen drug master file entries for this compound. Thirty-eight suppliers are listed for this compound. Additional details are available on the minocycline hydrochloride profile page.

Summary for ARESTIN
Drug patent expirations by year for ARESTIN
Drug Prices for ARESTIN

See drug prices for ARESTIN

Recent Clinical Trials for ARESTIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of MinnesotaPhase 4
Bausch Health Companies, INC.Phase 4
University of Minnesota - Clinical and Translational Science InstitutePhase 4

See all ARESTIN clinical trials

Pharmacology for ARESTIN

US Patents and Regulatory Information for ARESTIN

ARESTIN is protected by two US patents.

Patents protecting ARESTIN

Dispensing apparatus and cartridge
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Dispensing apparatus and cartridge with deformable tip
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Orapharma ARESTIN minocycline hydrochloride POWDER, EXTENDED RELEASE;DENTAL 050781-001 Feb 16, 2001 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Orapharma ARESTIN minocycline hydrochloride POWDER, EXTENDED RELEASE;DENTAL 050781-001 Feb 16, 2001 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for ARESTIN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Orapharma ARESTIN minocycline hydrochloride POWDER, EXTENDED RELEASE;DENTAL 050781-001 Feb 16, 2001 See Plans and Pricing See Plans and Pricing
Orapharma ARESTIN minocycline hydrochloride POWDER, EXTENDED RELEASE;DENTAL 050781-001 Feb 16, 2001 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for ARESTIN

See the table below for patents covering ARESTIN around the world.

Country Patent Number Title Estimated Expiration
Spain 2427272 See Plans and Pricing
Brazil 0308859 Aparelho de distribuiĆ§Ć£o e cartucho See Plans and Pricing
Australia 2003223384 DISPENSING APPARATUS AND CARTRIDGE See Plans and Pricing
Japan 4749672 See Plans and Pricing
European Patent Office 1489988 DISTRIBUTEUR ET CARTOUCHE (DISPENSING APPARATUS AND CARTRIDGE) See Plans and Pricing
Colombia 5611079 APARATO DISPENSADOR Y CAPSULA See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKinsey
Mallinckrodt
Merck
Johnson and Johnson
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.